Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy. - Laloi, Louise; Billotey, Natacha Chaumard; Dumas, Pierre‐Yves; Paul, Franciane; Villate, Alban; Simand, Célestine; Fornecker, Luc; Puisset, Florent; Bertoli, Sarah; Simonet, Marion Boissard; Laribi, Kamel; Houyou, Dyhia; et al. (Cancer Medicine, 2023)